RT Journal Article
SR Electronic
T1 Gestational age at birth and body size from infancy through adolescence: findings from analyses of individual data on 253,810 singletons in 16 birth cohort studies
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.06.01.22275859
DO 10.1101/2022.06.01.22275859
A1 Vinther, Johan L.
A1 Cadman, Tim
A1 Avraam, Demetris
A1 Ekstrøm, Claus T.
A1 Sørensen, Thorkild I.A.
A1 Elhakeem, Ahmed
A1 Santos, Ana C.
A1 de Moira, Angela Pinot
A1 Heude, Barbara
A1 Iñiguez, Carmen
A1 Pizzi, Costanza
A1 Simons, Elinor
A1 Voerman, Ellis
A1 Corpeleijn, Eva
A1 Zariouh, Faryal
A1 Santorelli, Gilian
A1 Inskip, Hazel M.
A1 Barros, Henrique
A1 Carson, Jennie
A1 Harris, Jennifer R.
A1 Nader, Johanna L.
A1 Ronkainen, Justiina
A1 Strandberg-Larsen, Katrine
A1 SantaMarina, Loreto
A1 Calas, Lucinda
A1 Cederkvist, Luise
A1 Popovic, Maja
A1 Charles, Marie-Aline
A1 Welten, Marieke
A1 Vrijheid, Martine
A1 Azad, Meghan
A1 Subbarao, Padmaja
A1 Burton, Paul
A1 Mandhane, Puishkumar J.
A1 Huang, Rae-Chi
A1 Wilson, Rebecca C.
A1 Haakma, Sido
A1 Fernández-Barrés, Sílvia
A1 Turvey, Stuart
A1 Santos, Susana
A1 Tough, Suzanne C.
A1 Sebert, Sylvain
A1 Fenton, Tanis
A1 Moraes, Theo J.
A1 Salika, Theodosia
A1 Jaddoe, Vincent W.V.
A1 Lawlor, Deborah A.
A1 Andersen, Anne-Marie Nybo
YR 2022
UL http://medrxiv.org/content/early/2022/06/03/2022.06.01.22275859.abstract
AB Background Preterm birth is the leading cause of perinatal morbidity and mortality, and is associated with adverse developmental and long-term health outcomes, including several cardio-metabolic risk factors. However, evidence about the association of preterm birth with later body size derives mainly from studies using birth weight as proxy of prematurity rather than actual length of gestation. We investigated the association of gestational age at birth (GA) with body size from infancy through adolescence.Methods and Findings We conducted a two-stage Individual Participant Data (IPD) meta-analysis using data from 253,810 mother-children dyads from 16 general population-based cohort studies in Europe, North America and Australasia to estimate the association of GA with standardized Body Mass Index (BMI) and overweight (including obesity) adjusted for confounders. Using a federated analytical tool (DataSHIELD), we fitted linear and logistic regression models in each cohort separately, and combined the regression estimates and standard errors through random-effects study-level meta-analysis providing an overall effect estimate at early infancy (>0.0-0.5 years), late infancy (>0.5-2.0 years), early childhood (>2.0-5.0 years), mid-childhood (>5.0-9.0 years), late childhood (>9.0-14.0 years) and adolescence (>14.0-19.0 years).GA was positively associated with BMI in the first decade of life with mean differences in BMI z-score (0.01-0.02) per week of increase in GA, however preterm infants reached similar levels of BMI as term infants by adolescence. The association of GA with risk of overweight revealed a similar pattern of results from late infancy through mid-childhood with an increased odds of overweight (OR 1.01-1.02) per week increase in GA. By adolescence, however, GA was slightly negatively associated with risk of overweight (OR 0.98 [95% CI: 0.97:1.00]) per week of increase in GA, and children born very preterm had increased odds of overweight (OR 1.46 [95% CI: 1.03; 2.08]) compared with term.The findings were consistent across cohorts and sensitivity analyses, despite considerable heterogeneity in cohort characteristics.Conclusion Higher GA is potentially clinically important for higher BMI in infancy, while the association attenuates consistently with age. By adolescence, preterm children have on average a similar mean BMI to those born term.Competing Interest StatementI have read the journal?s policy and the authors of this manuscript have the following competing interests: DAL has received support from Roche Diagnostics and Medtronic in relation to biomarker research that is not related to the research presented in this paper. The other authors have declared that no competing interests exist.Funding StatementThis collaborative project received funding from the European Union’s Horizon 2020 research and innovation programme 334 (Grant Agreement No. 733206 LifeCycle, Grant Agreement No. 824989 EUCAN-Connect). Please see S1 Appendix for list 335 of cohort-specific funding/support. DAL is supported by the UK Medical Research Council 336 (MC_UU_00011/6) and British Heart Foundation (CH/F/20/90003 and AA/18/7/34219). RW is supported by 337 UKRI Innovation Fellowship with Health Data Research UK [MR/S003959/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Not ApplicableData Availability Statement The data used for this study is third-party data, and without legally permission of distribution or public sharing. Information about data access and governance for this study is explained in detail in a peer-reviewed scientific paper by Prof. Vincent Jaddoe et al (2020): “The LifeCycle Project?EU Child Cohort Network: a federated analysis infrastructure and harmonized data of more than 250,000 children and parents”. The principal investigators or home institutions administer permission to the data for external researchers: hence, access to the data is conditional on reasonable request and with approval by each cohort. A description of the data set and third-party sources are listed in Supplementary Materials, and displayed online at the EU Child Cohort Variable Catalogue (https://data-catalogue.molgeniscloud.org/catalogue/catalogue/#/) and the Maelstrom Catalogue (https://www.maelstrom-research.org/page/catalogue).